SOVUNA Drug Patent Profile
✉ Email this page to a colleague
When do Sovuna patents expire, and what generic alternatives are available?
Sovuna is a drug marketed by Novitium Pharma and is included in one NDA.
The generic ingredient in SOVUNA is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sovuna
A generic version of SOVUNA was approved as hydroxychloroquine sulfate by TEVA PHARMS on September 30th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SOVUNA?
- What are the global sales for SOVUNA?
- What is Average Wholesale Price for SOVUNA?
Summary for SOVUNA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| What excipients (inactive ingredients) are in SOVUNA? | SOVUNA excipients list |
| DailyMed Link: | SOVUNA at DailyMed |
Pharmacology for SOVUNA
| Drug Class | Antimalarial Antirheumatic Agent |
US Patents and Regulatory Information for SOVUNA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novitium Pharma | SOVUNA | hydroxychloroquine sulfate | TABLET;ORAL | 214581-001 | Jan 14, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novitium Pharma | SOVUNA | hydroxychloroquine sulfate | TABLET;ORAL | 214581-002 | Jan 14, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
